The Collaborative Community on Ophthalmic Innovation

 
 

Innovation Day Program Schedule (February 4, 2026)

Opening Session
08:00–09:00
Grand Ballroom

Moderators: Malvina EYDELMAN (U.S.) & Daniel TING (Singapore)
Daniel TING (Singapore)
08:00–08:03 – Welcome

Malvina EYDELMAN (U.S.)
08:03–08:12 – CCOI: Catalyst for Bringing Asia-Pacific Ophthalmic Innovation to Global Markets

CULTURAL PERFORMANCE
08:12–08:20 – Face-Changing

Hugh TAYLOR (Australia)
08:20–08:35 – Keynote Lecture 1: From Discovery to Delivery — Building the Path to Vision Care at Scale

Emmett CUNNINGHAM (U.S.), Hugh TAYLOR (Australia), Adrienne GRAVES (U.S.), Malvina EYDELMAN (U.S.) & Daniel TING (Singapore)
08:35–08:55 – Keynote Roundtable: Building a Sustainable Asia-Pacific Innovation Platform

Session 1: Defining the Future – Establishing Standard Terminology & Endpoints for Oculomics
09:00–11:05
Grand Ballroom

Chairs: Carol CHEUNG (Hong Kong) & Vinit MAHAJAN (U.S.)
Alvin LIU (U.S.)
09:00–09:08 – Why Do We Need to Standardize Endpoints in Oculomics?

Cecilia LEE (U.S.)
09:08–09:16 – Oculomics as Pre-Screening, Screening, or Opportunistic Screening Tool?

Daniela FERRARA (U.S.)
09:16–09:24 – Oculomics Research for Systemic Disease Prediction: Ophthalmology at the Center of Healthcare

Vincent MOK (Hong Kong)
09:24–09:32 – Case Study – Endpoints of Brain Health

Tyler RIM (South Korea)
09:32–09:40 – Case Study – Endpoints of Cardiovascular Risk

Avantika NAIDU (U.S.)
09:40–09:48 – Oculometrics in Oculomics

Ryo KAWASAKI (Japan)
09:48–09:56 – How Can We Implement Oculomics Screening in the Context of Nation-Wide Health Checkups in Japan?

Leanne LABRIOLA (U.S.)
09:56–10:04 – Incorporating Tear Fluid Biomarkers in Oculomics

Vinit MAHAJAN (U.S.)
10:04–10:12 – Expanding Oculomics through AI, Proteomics, EHR, and Imaging Data

Michael MCCONNELL (U.S.)
10:12–10:20 – Oculomics for Cardio-Kidney-Metabolic
Health​​​

Lisa ZHU (Australia)
10:20–10:28 – Oculomics for Diabetes Complications

Tien WONG (China)
10:28–10:36 – What Should the Oculomics Ecosystem Look Like?

Elvin NG (U.S.)
10:36–10:44 – From Innovation to Approval: The Regulatory Pathway for Oculomics

10:44–11:05 – Panel Discussion
Panelists: Kevin CHOI (South Korea), Malvina EYDELMAN (U.S.), Aaron LEE (U.S.), Malcolm NGIAM (Singapore), Anran RAN (Hong Kong), Yih Chung THAM (Singapore), All Chairs & Speakers

Session 2a: Bringing Ophthalmic Innovations into the Real World – Crossing the Academic Valley of Death
09:00–10:00
Grand III, IV & Annex

Moderator: Emmett CUNNINGHAM (U.S.) & Daniel TING (Singapore)
Panelists
Anand SIVARAMAN (India/Remedio)
Mingguang HE (Hong Kong)
Paisan RUAMVIBOONSUK (Thailand)
Tien WONG (China)
Donald C. HOOD (U.S.)
Rainny XIE (Singapore)

Session 2b: AI Adoption in the Eye Industries: Now and Future
10:00–11:00
Grand III, IV & Annex

Moderator: Daniel TING (Singapore)
Panelists
Shannon SPOCK (U.S./Alcon)
Olga PRENAT (France/Essilor)
Greg KUNST (U.S./Valitor)
Jodie MADDEN (Singapore/Astellas)
Ram PALANKI (U.S./Regenxbio)
Lavin ACHUDAN (Singapore/Santen)
Fabio BASCHIERA (Germany/Boehringer)
Danny SOON (Singapore/CRIS)
Pengtat CHEONG (Taiwan/ZEISS)

Coffee Break
11:00–11:30
Foyer

Session 3: Glaucoma Innovation
11:30–12:50
Grand Ballroom

Chairs: Joel SCHUMAN (U.S.) & Lama AL-ASWAD (U.S.)
Joel SCHUMAN (U.S.)
11:30–11:37 – CCOI and Glaucoma Innovation: Origins, Impact, and the Road Ahead

Donald C. HOOD (U.S.)
11:37–11:44 – A Pattern-Based OCT Metric with AI for Glaucoma Detection Outperforms Conventional Metrics

Philippe ANDREUCCI (France)
11:44–11:51– Microbattery

Kfir AZOULAY (Germany)
11:51–11:58 – What Industry Must Do Now to Transform Glaucoma’s Trajectory

Ariel CAO (U.S.)
11:58–12:05 – Innovation in Intraocular Pressure Sensors

Chris LEUNG (Hong Kong)
12:05–12:12 – Summary from the SIGMA Summit

Gopalan BALAJI (U.S.)
12:12–12:19 – Gore GDI – Device Design, Materials of Construction and their Influence on Clinical Results

George KONG (Australia)
12:19–12:26 – Innovating Glaucoma Visual Field Testing: How MRF Online Perimetry Enables Accessible and Scalable Glaucoma Care in Asia and Beyond

Lama AL-ASWAD (U.S.)
12:26–12:33 – Shaping Global Standards for Glaucoma Endpoints: What’s Next

12:33–12:50 – Panel Discussion
Panelists: Adrienne GRAVES (U.S.), Tina WONG (Singapore), All Chairs & Speakers

Session 4: Anterior Segment – Innovation & Regenerative Medicine
11:30–12:50
Grand III, IV & Annex

Chairs: Natalie AFSHARI (U.S.), Ying JIE (China) & Tomohiko USUI (Japan)
Natalie AFSHARI (U.S.)
11:30–11:38 – Emerging Technologies in Corneal & Cataract Surgery

Anuraag SINGH (U.S.)
11:38–11:46 – Device Design, Materials of Construction, and Their Contribution to Improved Clinical Outcomes

Nahum FERERA (Israel)
11:46–11:54 – EndoArt®: Redefining Corneal Edema Care

Tomohiko USUI (Japan)
11:54–12:02 – Clinical Experience of Regenerative Therapy for Refractory Corneal Diseases

Ying JIE (China)
12:02–12:10 – Novel Approaches in Corneal Repair

Jod MEHTA (Singapore)
12:10–12:18 – Updates on Cornea & Refractive Laser

Sunil SHAH (United Kingdom)
12:18–12:26 – Mission Impossible? Exploring Photon-UVC as a Non-Antibiotic Strategy for Infectious Keratitis

12:26–12:50 – Panel Discussion
Panelists: All Chairs & Speakers

Networking Lunch
12:50–13:50
Grand Ballroom

Cathy TRUITT (Alcon R&D Seed Fund Head) &
Shannon SPOCK (Alcon Search & Evaluation Head, BD&L)
12:50–13:10 – Alcon External Innovation Partnerships & Investments

BUFFET LUNCH
13:10–13:50

Keynote Plenary: Shaping the Future of Vision Innovation
13:50–14:30
Grand Ballroom

Moderators: Malvina EYDELMAN (U.S.)
S. Robert LEVINE (U.S.)
13:50–14:10 – Keynote Lecture 2: The DRD Cure Accelerator — A New Model for Translating Science into Impact

Neil BRESSLER (U.S.)
14:10–14:30 – Keynote Lecture 3: The Global Evidence Engine — How JAMA Ophthalmology Accelerates Innovation

Session 5: Global Innovation Landscape in Retina
14:30–16:00
Grand Ballroom

Chairs: Leanne LABRIOLA (U.S.) & Stela VUJOSEVIC (Italy)
Rainny XIE (Singapore)
14:30–14:38 – Opportunities and Challenges of Early-Stage Health Innovation in Singapore

Remko BAKKER (Germany)
14:38–14:46 – Shaping Eye Health Strategy – A Pharma Perspective

Greg KUNST (U.S.)
14:46–14:54 – The Future of Anti-VEGFs: Can We Re-define How We Treat Our Patients?

Sri MUDUMBA (U.S.)
14:54–15:02 – New Drug Pipelines in IRD Space

Stela VUJOSEVIC (Italy)
15:02–15:10 – New Drug Pipelines in AMD and DME: Can AI Help?

Roomasa CHANNA (U.S.)
15:10–15:18 – Global Benchmark for AMD Algorithm Validation: Defining the Primary End Points for Clinical Trials

Omer TRIVIZKI (Israel)
15:18–15:26 – Setting Standards for AI in Retinal Imaging: A Joint CCOI–IntRIS Consensus on AMD OCT

Elvin NG (U.S.)
15:26–15:34 – US Regulatory Perspective and Opportunities for Innovation

15:34–16:00 – Panel Discussion
Panelists: Ram PALANKI (U.S.), All Chairs & Speakers

Session 6: Imaging Innovation
14:30–16:00
Grand III, IV & Annex

Chairs: Donald C. HOOD (U.S.) & Chris LEUNG (Hong Kong)
Ashley KRAS (Australia)
14:30–14:38 – Why Interoperability Will Define the Next Era of Innovation in Eye Care

Chris LEUNG (Hong Kong)
14:38–14:46 – AI-Powered Imaging for Glaucoma Screening at Scale: The HKU × Orbis ROTA Experience

Donald C. HOOD (U.S.)
14:46–14:54 – The Ground Truth for Deep Learning Models for Glaucoma Detection

Daniela FERRARA (U.S.)
14:54–15:02 – Imaging Endpoints in Clinical Trials – Where Are We Heading?

Eisuke SHIMIZU (Japan)
15:02–15:10 – AI/Imaging Startups: From Prototype to Practice

Paul CHAN (U.S.)
15:10–15:18 – Using AI to Change Clinical Flow & Optimize Efficiency

Ashvin AGARWAL (India)
15:18–15:26 – Pinhole Puiloplasty for Irregular Cornea

15:26–16:00 – Panel Discussion
Panelists: All Chairs & Speakers

Coffee Break
16:00–16:30
Foyer

Session 7: Robotics Innovation
16:30–18:00
Grand Ballroom

Chairs: Malvina EYDELMAN (U.S.), Stephen MCLEOD (U.S.), Shameema SIKDER (U.S.) & Koh-Hei SONODA (Japan)
Stephen MCLEOD (U.S.)
16:30–16:38 – Robotic Innovation in Ophthalmology

Haotian LIN (China)
16:38–16:46 – Robotics and Automation in Ophthalmic Care Pathways

Marc D. de SMET (Switzerland)
16:46–17:54– Innovation and Regulation – Partners to Accelerate Development

Binita ASHAR (U.S.)
17:54–17:02 – What Robotics and AI Will Change About Ophthalmic Surgery

Koh-Hei SONODA (Japan)
17:02–17:10 – Robotics in Vitreoretinal Surgeries

Shameema SIKDER (U.S.)
17:10–17:18 – Enabling Autonomous Intelligence in Cataract Surgery

David CHANG (U.S.)
17:18–17:26 – Robotic Cataract Surgery – Threat or Remedy?

Tieuvi NGUYEN (U.S.)
17:26–17:34 – From Innovation to Adoption: Regulating Robotics in Ophthalmology

17:34–18:00 – Panel Discussion
Panelists: All Chairs & Speakers

Closing
18:00–18:10
Grand Ballroom

Malvina EYDELMAN (U.S.) & Daniel TING (Singapore)
18:00–18:10 – Closing Remarks